GNPDA2 and cancer: For instance, for GNPDA2 gene in LIHC patients, four clinical factors (gender (Figure 4(a), P = 1.1E − 3), race (Figure 4(b), P = 1E − 4), tumor grade (Figure 4(c), P = 4.4E − 2), and BMI (Figure 4(d), P = 2.1E − 2)) influenced the Kaplan–Meier survival curves in cancer tissues with different expression levels of the GNPDA2 gene.